Sarepta Therapeutics, Inc. logo

Sarepta Therapeutics, Inc.

NASDAQ:SRPT

Overview | Financials
Company Name Sarepta Therapeutics, Inc.
Symbol SRPT
Currency USD
Price 17.71
Market Cap 1,740,485,670
Dividend Yield 0%
52-week-range 16.88 - 156.7
Industry Biotechnology
Sector Healthcare
CEO Mr. Douglas S. Ingram Esq.
Website https://www.sarepta.com

An error occurred while fetching data.

About Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that

Related Stocks

Nutex Health, Inc. logo

Nutex Health, Inc.

NUTX

131.8 USD

R1 RCM Inc. logo

R1 RCM Inc.

RCM

14.31 USD

ShockWave Medical, Inc. logo

ShockWave Medical, Inc.

SWAV

334.75 USD

Sotera Health Company logo

Sotera Health Company

SHC

11.45 USD

Exelixis, Inc. logo

Exelixis, Inc.

EXEL

43.62 USD

Halozyme Therapeutics, Inc. logo

Halozyme Therapeutics, Inc.

HALO

52.92 USD

10x Genomics, Inc. logo

10x Genomics, Inc.

TXG

12.06 USD

Financials

Numbers are in millions USD

Numbers are in millions USD